Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Particle Sciences is opening a new commercial drug product manufacturing facility at the end of 2018 at its existing site in Bethlehem, PA.
read more
Tuesday, October 07, 2025
CELONIC GROUP and the Carbogen Amcis Group announced a strategic partnership to offer a fully integrated Antibody-Drug Conjugate (ADC) development and manufacturing solution. The alliance combines Celonic’s advanced biologics capabilities with ...
read more
Vaccizone has selected Exothera S.A. to fast-track process development of its SARS-CoV-2 vaccine for European clinical trials.
read more
Wednesday, August 17, 2022
Emery Pharma has expanded its lab. The extension of its new laboratory is streamlined to support research and development of large molecule drugs including, biologics, antibody-drug conjugates, biosimilars and others.
read more
Wednesday, February 13, 2019
Recipharm has appointed a new director of business management for the USA and Canada.
read more
ProThera Biologics and Takeda have entered into a global licensing agreement to develop a novel plasma-derived IAIP therapy for the treatment of acute inflammatory conditions.
read more
Thursday, November 28, 2013
ResearchDx, LLC of Irvine, California, USA today announced an expansion of its operations to focus on the important Indian biopharmaceutical and diagnostics markets.
read more
BiondVax developer of the Universal Flu Vaccine candidate M-001, announced the signing of a MSA with a CRO to conduct the first pivotal, clinical efficacy, Phase 3 trial of M-001.
read more
Tuesday, January 05, 2021
Stäubli has announced a new Chief Executive Officer.
read more
Wednesday, September 25, 2019
Certara® announced the FDA has renewed licenses for Synchrogenix’s electronic Common Technical Document review software, GlobalSubmit REVIEW™ and GlobalSubmit VALIDATE™.
read more
Wednesday, March 11, 2020
Ajinomoto Bio-Pharma announced the formation of its External Advisory Board (EAB) to provide insight into industry trends and high-level advice to the Company’s leadership team.
read more
Parexel announced its collaboration with CluePoints, a provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software.
read more
Wednesday, August 28, 2019
Water Street Healthcare Partners and JLL Partners have acquired THREAD, a provider of technology that enables virtual research approaches to modernize clinical studies and registries.
read more
Mabion S.A., a Polish biotechnology company, has signed a letter of intent (LoI) with French TechDev company Oddifact SAS to evaluate and advance MabionCD20 for potential use in rare diseases.
read more
EyePoint has entered into a purchase and marketing agreement with Vantage Outsourcing for Dexycu.
read more